Solstein Capital, LLC Vertex Pharmaceuticals Inc Transaction History

Solstein Capital, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 27, 2021	SELL	$181.39 - $202.99 $6,348 - $7,104	-35 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$207.02 - $241.31 $7,245 - $8,445	35 New	35 $8,000
Q1 2020 May 12, 2020	SELL	$199.77 - $247.81 $16,580 - $20,568	-83 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$166.71 - $223.91 $13,836 - $18,584	83 New	83 $18,000

1,724

222M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $119B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Solstein Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Solstein Capital, LLC with notifications on news.